Optimal doses of rifampicin in the standard drug regimen to shorten tuberculosis treatment duration and reduce relapse by eradicating persistent bacteria. (2018)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1093/jac/dkx467
PubMed Identifier: 29244108
Publication URI: http://europepmc.org/abstract/MED/29244108
Type: Journal Article/Review
Volume: 73
Parent Publication: The Journal of antimicrobial chemotherapy
Issue: 3
ISSN: 0305-7453